Sun Pharmaceutical Industries has appointed Shaik Barak Tulla as Senior Vice President, marking a decisive step in bolstering its commercial strategy and innovation-led growth. With over 25 years of experience in the pharmaceutical industry, Tulla brings a track record of transformative leadership, strategic foresight, and people-first execution.

Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla, where he led one of the largest business clusters with a P&L responsibility of INR 1800 Cr ($225 million) and oversaw seven business units and 2,500 employees. Reporting directly to the CEO of Cipla’s One India Business, Tulla’s leadership saw the Acute Cluster rise in both profitability and therapy area dominance, notably in respiratory, anti-infectives, and critical care.

With proven success in AI-driven commercial planning, Sales Force Effectiveness (SFE), and building high-performance teams, Shaik significantly boosted revenues and minimized attrition. At Sun Pharma, he will lead commercial strategy, innovation, and business acceleration across key markets, aligning with the company’s mission of delivering affordable, high-quality healthcare.